In patients with stable heart failure, soluble TNF-receptor 2 is associated with increased risk for depressive symptoms

Biological Research for Nursing

Volumn 16, Issue 3, 2014, Pages 295-302

  Moughrabi, Samira ^a   Evangelista, Lorraine S ^b   Habib, Samer I ^c   Kassabian, Leo ^d   Breen, Elizabeth Crabb ^e   Nyamathi, Adeline ^f   Irwin, Michael ^e  

^a CALIFORNIA STATE UNIVERSITY   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c JULES STEIN EYE INSTITUTE   (United States)

^d Cardiovascular Medical Group   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CRP; Depressive symptoms; Heart failure; IL 6; Inflammation; TNF receptors; TNF

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; BLOOD; CHRONIC DISEASE; COMPLICATION; DEPRESSION; FEMALE; HEART FAILURE; HUMAN; MALE; MIDDLE AGED; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; C-REACTIVE PROTEIN; CHRONIC DISEASE; DEPRESSION; FEMALE; HEART FAILURE; HUMANS; INTERLEUKIN-6; MALE; MIDDLE AGED; RECEPTORS, TUMOR NECROSIS FACTOR, TYPE II;

EID: 84904998966     PISSN: 10998004     EISSN: 15524175     Source Type: Journal    
DOI: 10.1177/1099800413496454     Document Type: Article

References (42)

1. Alonso-Martinez, J. L., Llorente-Diez, B., Echegaray-Agara, M., Olaz-Preciado, F., Urbieta-Echezarreta, M., & Gonzalez-Arencibia, C. (2002). C-reactive protein as a predictor of improvement and readmission in heart failure. European Journal of Heart Failure, 4, 331-336.
2. Aziz, N., Fahey, J. L., Detels, R., & Butch, A. W. (2003). Analytical performance of a highly sensitive C-reactive protein-based immunoassay and the effects of laboratory variables on levels of protein in blood. Clinical and Diagnostic Laboratory Immunology, 10, 652-657.
3. Bozkurt, B. Mann, D. L., & Deswal, A. (2010). Biomarkers of inflammation in heart failure. Heart Failure Review, 15, 331-341.
4. Deswal, A., Petersen, N. J., Feldman, A. M., Young, J. B., White, B. G., & Mann, D. L. (2001). Cytokines and cytokine receptors in advanced heart failure: An analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation, 103, 2055-2059.
5. Dibbs, Z., Thornby, J., White, B. G., & Mann, D. L. (1999). Natural variability of circulating levels of cytokines and cytokine receptors in patients with heart failure: Implications for clinical trials. Journal of the American College of Cardiology, 33, 1935-1942.
6. Douglas, K. M., Taylor, A. J., & O'Malley, P.G. (2004). Relationship between depression and C-reactive protein in a screening population. Psychosomatic Medicine, 66(5): 679-683.
7. Ferketich, A. K., Ferguson, J. P., & Binkley, P. F. (2005). Depressive symptoms and inflammation among heart failure patients. American Heart Journal, 150, 132-136.
8. Ferrari, R., Bachetti, T., Confortini, R., Opasich, C., Febo, O., Corti, A., Visioli, O. (1995). Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation, 92, 1479-1486.
9. Ford, D. E., & Erlinger, T. P. (2004). Depression and C-reactive protein in US adults: Data from the third national health and nutrition examination survey. Archives of Internal Medicine, 164, 1010-1014.
10. Holzapfel, N., Muller-Tasch, T., Wild, B., Junger, J., Zugck, C., Remppis, Lowe, B. (2008). Depression profile in patients with and without chronic heart failure. Journal of Affective Disorders, 105, 53-62.
11. Howren, M. B., Lamkin, D. M., & Suls, J. (2009). Associations of depression with C-reactive protein, IL-1, and IL-6: A meta-analysis. Psychosomatic Medicine, 71, 171-186.
12. Jiang, W., Alexander, J., Christopher, E., Kuchibhatla, M., Gaulden, L. H., Cuffe, M. S., O'Connor, C. M. (2001). Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Archives of Internal Medicine, 161, 1849-1856.
13. Johansson, P., Lesman-Leegte, I., Svensson, E., Voors, A., van Veldhuisen, D. J., & Jaarsma, T. (2011). Depressive symptoms and inflammation in patients hospitalised for heart failure. American Heart Journal, 161, 1053-1059.
14. Kroenke, K., Spitzer, R. L., & Williams, J. B. (2001). The PHQ-9: Validity of a brief depression severity measure. Journal of General Internal Medicine, 16, 606-613.
15. Kubera, M., Kenis, G., Bosmans, E., Kajta, M., Basta-Kaim, A., Scharpe, S., Maes, M. (2004). Stimulatory effect of antidepressants on the production of IL-6.
16. International Immunopharmacology, 4, 185-192.
17. Kubera, M., Kenis, G., Budziszewska, B., Bosmans, E., Scharpe, S., Basta-Kaim, A., & Maes, M. (2001). Lack of modulatory effect of imipramins on glugocorticoid-induced suppression of interferon-gamma and interleukin-10 production in vitro. Polish Journal of Pharmacology, 53, 289-294.
18. Maes, M. (2001). The immunoregulatory effects of antidepressants. Human Psychopharmacology, 16, 95-103.
19. Maes, M., Song, C., Lin, A. H., Bonaccorso, S., Kenis, G., De Johng, R., Scharpe, S. (1999). Negative immunoregulatory effects of antidepressants: Inhibition of interferon-gamma and stimulation of interleukin-10 secretion. Neuropsychopharmacology, 20, 370-379.
20. Marcucci, R., Gori, A. M., Giannotti, F., Baldi, M., Verdiani, V., Del Pace, S., Abbate, R. (2006). Markers of hypercoagulability and inflammation predict mortality in patients with heart failure. Journal of Thrombosis and Haemostasis, 4, 1017-1022.
21. Martin, A., Rief, W., Klaiberg, A., & Braehler, E. (2006). Validity of the brief patient health questionnaire mood scale (PHQ-9) in the general population. General Hospital Psychiatry, 28, 71-77.
22. Moorman, A. J., Mozaffarian, D., Wilkinson, C. W., Lawler, R. L., McDonald, G. B., Crane, B. A., Levy, W. C. (2007). In patients with heart failure elevated soluble TNF-receptor 1 is associated with higher risk of depression. Journal of Cardiac Failure, 13, 738-743.
23. Muller-Tasch, T., Peters-Klimm, F., Schellberg, D., Holzapfel, N., Barth, A., Junger, J., Herzog W. (2007). Depression is a major determinant of quality of life in patients with chronic systolic heart failure in general practice. Journal of Cardiac Failure, 13, 818-824.
24. Nozaki, N., Yamaguchi, S., Shirakabe, M., Nakamura, H., & Tomoike, H. (1997). Soluble tumor necrosis factor receptors are elevated in relation to severity of congestive heart failure. Japanese Circulation Journal, 61, 657-664.
25. Parissis, J. T., Adamopoulos, S., Rigas, A., Kostakis, G., Karatzas, D., Venetsanou, K., & Kremastinos, D. T. (2004). Comparison of circulating proinflammatory cytokines and soluble apoptosis mediators in patients with chronic heart failure with versus without symptoms of depression. American Journal of Cardiology, 94, 1326-1328.
26. Parissis, J. T., Farmakis, D., Nikolaou, M., Birmpa, D., Bistola, V., Paraskevaidis, I., Kremastinos D. T (2009) B-type natriuretic peptide and anti-inflammatory cytokine interleukin-10 levels predict adverse clinical outcome in chronic heart failure patients with depressive symptoms: A 1-year follow-up study. European Journal of Heart Failure, 11, 967-972.
27. Pasic, J., Levy, W. C., & Sullivan, M. D. (2003). Cytokines in depression and heart failure. Psychosomatic Medicine, 65, 181-193.
28. Phelan, E. Williams, B. Meeker, K. Bonn, K. Frederick, J. Logerfo, J. & Snowden, M. (2010). A study of the diagnostic accuracy of the PHQ-9 in primary care. BMC Family Practice, 11, 63-71.
29. Redwine, L. S., Mills, P. J., Hong, S., Rutledge, T., Reis, V., Maisel, A., & Irwin, M. R. (2007). Cardiac-related hospitalization and/or death associated with immune dysregulation and symptoms of depression in heart failure patients. Psychosomatic Medicine, 69, 23-29.
30. Roger, V. L. Go, A. S. Lloyd-Jones, D.M. Adams, R. J. Berry, J. D. Brown, T. M. Wylie-Rosett, J., on behalf of the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. (2011). Heart disease and stroke statistics-2011 update: A report from the American Heart Association. Circulation, 123, e18-e209.
31. Rumsfeld, J. S., Jones, P. G. Whooley, M. A., Sullivan, M. D., Pitt, B., Weintraub, W. S., & Spertus, J. A. (2005). Depression predicts mortality and hospitalization in patients with myocardial infarction complicated by heart failure. American Heart Journal, 150, 961-967.
32. Sato, Y., Takatsu, Y., Kataoka, K., Yamada, T., Taniguchi, R., Sasayama, S., & Matsumori, A. (1999). Serial circulating concentrations of C-reactive protein, interleukin (IL)-4, and IL-6 in patients with acute left heart decompensation. Clinical Cardiology, 22, 811-813.
33. Sherwood, A., Blumenthal, J. A., Trivedi, R., Johnson, K. S., O'Connor, C. M., Adams, K. F., Jr., Hinderliter, A. L. (2007). Relationship of depression to death or hospitalization in patients with heart failure. Archives of Internal Medicine, 167, 367-373.
34. Sullivan, M., Simon, G., Spertus, J., & Russo, J. (2002). Depressionrelated costs in heart failure care. Archives of Internal Medicine, 162, 1860-1866.
35. Torre-Amione, G., Kapadia, S., Benedict, C., Oral, H., Young, J. B., & Mann, D. L. (1996). Proinflammatory cytokine levels in patients with depressed left ventricular ejection fraction: A report from the studies of left ventricular dysfunction (SOLVD). Journal of the American College of Cardiology, 27, 1201-1206.
36. Tousoulis, D., Droias, A., Antoniades, C., Vasiliadou, C., Marinou, K., Latsios, G., Stefanadis, C. (2009). Antidepressive treatment as a modulator of inflammatory process in patients with heart failure: Effects on proinflammatory cytokines and acute phase protein levels. International Journal of Cardiology, 134, 238-243.
37. Vaccarino, V., Kasl, S. V., Abramson, J., & Krumholz, H. M. (2001). Depressive symptoms and risk of functional decline and death in patients with heart failure. Journal of the American College of Cardiology, 38, 199-205.
38. Vasan, R. S., Sullivan, L. M., Roubenoff, R., Dinarello, C. A., Harris, T., Benjamin, E. J., Wilson, P.W. (2003). Inflammatory markers and risk of heart failure in elderly subjectswithout priormyocardial infarction: The Framingham Heart Study. Circulation, 107, 1486-1491.
39. Villacorta, H., Masetto, A. C., & Mesquita, E. T. (2007). C-reactive protein: An inflammatory marker with prognostic value in patients with decompensated heart failure. Arquivos Brasilerios de Cardiology, 88, 585-589.
40. Whooley, M. A., Caska, C. M., Hendrickson, B. E., Rourke, M. A., Ho, J., & Ali, S. (2007). Depression and inflammation in patients with coronary heart disease: Findings from the heart and soul study. Biological Psychiatry, 62, 314-320.
41. Wirtz, P. H., Redwine, L. S., Linke, S., Hong, S., Rutledge, T., Greenberg, B. H., & Mills, P. J. (2010). Circulating levels of soluble intercellular adhesion molecule-1 (sICAM-1) independently predict depressive symptom severity after 12 months in heart failure patients. Brain Behavior and Immunity, 24, 366-369.
42. Xia, Z., DePierre, J. W., & Nassberger, L. (1996). Tricyclic antidepressants inhibit IL-6, IL-1 beta and TNF-alpha release in human blood monocytes and IL-2 and interferon-gamma in T cells. Immunopharmacology, 34, 27-37.